| Nicholas N. Desantis Dpm | |
|
2306 6th Ave, San Diego, CA 92101-1643 | |
| (619) 239-3286 | |
| (619) 239-0172 |
| Full Name | Nicholas N. Desantis Dpm |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 2306 6th Ave, San Diego, California |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164736476 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | E2474 (California) | Primary |
| Provider Name | Nicholas N Desantis |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1053317545 PECOS PAC ID: 8921079120 Enrollment ID: I20040802001602 |
News Archive
A new study from the Stanford University School of Medicine has found that once U.S. patients visit a doctor for outpatient care, their race and ethnicity make little difference in the quality of care they receive.
People are often told to reduce their cholesterol to improve their heart health, but new research suggests that low cholesterol may increase kidney cancer patients' risk of dying from their disease. The findings, which are published in BJU International, indicate that cholesterol testing may help doctors as they monitor and treat patients with kidney cancer.
The global treaty that headed off destruction of earth's protective ozone layer has also prevented major disruption of global rainfall patterns, even though that was not a motivation for the treaty, according to a new study in the Journal of Climate.
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that it has engaged the Numoda Corporation, a leading information, process and logistics management company, to oversee the Phase III clinical trial of DAVANAT and 5-FU compared with the standard of care in the treatment of patients with advanced, metastatic colorectal cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas N. Desantis Dpm 2306 6th Ave, San Diego, CA 92101-1643 Ph: (619) 239-3286 | Nicholas N. Desantis Dpm 2306 6th Ave, San Diego, CA 92101-1643 Ph: (619) 239-3286 |
News Archive
A new study from the Stanford University School of Medicine has found that once U.S. patients visit a doctor for outpatient care, their race and ethnicity make little difference in the quality of care they receive.
People are often told to reduce their cholesterol to improve their heart health, but new research suggests that low cholesterol may increase kidney cancer patients' risk of dying from their disease. The findings, which are published in BJU International, indicate that cholesterol testing may help doctors as they monitor and treat patients with kidney cancer.
The global treaty that headed off destruction of earth's protective ozone layer has also prevented major disruption of global rainfall patterns, even though that was not a motivation for the treaty, according to a new study in the Journal of Climate.
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that it has engaged the Numoda Corporation, a leading information, process and logistics management company, to oversee the Phase III clinical trial of DAVANAT and 5-FU compared with the standard of care in the treatment of patients with advanced, metastatic colorectal cancer.
› Verified 9 days ago
Dr. Donald Triolo, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 6699 Alvarado Rd, Suite 2201, San Diego, CA 92120 Phone: 619-583-8160 Fax: 619-583-8170 | |
Dr. Anthony Michael Rabaiotti, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 2650 Stockton Rd, San Diego, CA 92106 Phone: 619-524-0087 | |
Dr. Sophie I Liu, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 7297 Ronson Rd Ste H, San Diego, CA 92111 Phone: 858-278-6603 | |
Dr. Arthur Wells Ward, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 35000 Guadalcanal Ave, Mcrd Branch Medical Clinic, San Diego, CA 92140 Phone: 619-524-8313 | |
Joseph Bui, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 5354 University Ave # 2, San Diego, CA 92105 Phone: 619-354-8370 | |
Dr. Jerome Anthony Wisniew, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2306 6th Ave, San Diego, CA 92101 Phone: 619-232-0179 | |
Dr. Roy Phillips Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3670 Clairemont Dr, Suite #7, San Diego, CA 92117 Phone: 858-272-1091 Fax: 866-401-4918 |